Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working

New York Times - Sep 30, 2026

Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.

Read full article

More News

24-7 Reporters

24-7 Reporters publishes up-to-the-minute news 24 hours a day, 7 days a week. Our certified reporters are among the most experienced, well-trained and talented across the globe, covering issues resonating progressives in every corner of the world.

Sign Up